# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Marilyn Monroe (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML002-SYN
- Date: 2026-10-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Joanna Whitlock, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Four-month review: physical therapy, follow-up ultrasound, mood, and pregnancy plans. **S**

## History of present illness

Ms. Monroe returns six weeks after the three-month visit, having had six sessions of pelvic floor physical therapy. She does her home program most days. Pain with intercourse is now mild and occasional, and her worst pelvic pain in the past week was 2 of 10. She continues the continuous pill with no periods and has used naproxen on two days this month. Her repeat transvaginal ultrasound this morning was reviewed by Dr. Okoye. She has had no thoughts of suicide or self-harm. She and her spouse want to begin trying for a pregnancy in about eight months, and she asks what the steps will be. **S**

| Element | Detail |
|---|---|
| Physical therapy | Six sessions; home program most days |
| Pain | Worst 2 of 10; mild, occasional pain with intercourse |
| Treatment | Continuous combined pill; naproxen on two days this month |
| Mood | PHQ-9 4, GAD-7 3 |
| Pregnancy plans | Would like to begin trying in about eight months |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Genitourinary | Negative | No bleeding; only mild, occasional pain with intercourse; no urinary symptoms |
| Gastrointestinal | Negative | No bowel pain |
| Musculoskeletal | Negative | No hip or back pain |
| Psychiatric | Negative | Mood good; no thoughts of suicide or self-harm |

4 systems reviewed. **S**

## Current medications

- Naproxen 500 mg oral tablet, one tablet by mouth twice daily with food, from two days before an expected bleed until the third day, and for pain flares; no more than 10 days a month **S**
- Ethinyl estradiol 0.02 mg and norethindrone acetate 1 mg oral tablet, one tablet by mouth daily, taken continuously without a pill-free week **S**
- Folic acid 0.4 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 112/70 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 56.6 kg; BMI 20.5 kg/m². All vital signs are synthetic.

PHQ-9: 4; GAD-7: 3; Pelvic pain, worst in the past week (0 to 10): 2. All results are synthetic.

## Change since baseline

- PHQ-9: 12 at baseline, 4 at this visit **S**
- GAD-7: 8 at baseline, 3 at this visit **S**
- Pelvic pain, worst in the past week (0 to 10): 8 at baseline, 2 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 112/70, pulse 70; weight 56.6 kg |
| Pelvic | Levator ani muscles relaxed, with only slight tenderness on the left; mild left adnexal fullness; no nodule |
| Psychiatric | Euthymic; engaged; organized |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Endometriosis with a left ovarian endometrioma** (N80.102). Well controlled. The repeat ultrasound shows the left endometrioma at 3.1 by 2.6 cm, slightly smaller, with the same typical features and no deep disease. Dr. Okoye reviewed it and agrees that no surgery is needed. Pregnancy plan: a preconception visit before she stops the pill in about eight months; folic acid continues; endometriosis pain may return off the pill, and naproxen should be stopped once she could be pregnant; reproductive endocrinology referral if she is not pregnant after six months of trying, or sooner if pain returns strongly. **S**
   - Continue the continuous combined pill until the preconception visit.
   - Ultrasound yearly, or sooner if pain changes.
   - Preconception visit in about seven months.
2. **Pelvic floor muscle dysfunction with myofascial pain** (M62.89). Much improved after six sessions. **S**
   - Two more sessions, then the home program.
3. **Major depressive disorder, single episode, moderate** (F32.1). PHQ-9 4: remission, with cognitive behavioral therapy. GAD-7 3. Safety reviewed: no thoughts of suicide or self-harm; the safety plan stays in her phone. **S**
   - Therapy monthly for several months to prevent relapse.
   - PHQ-9 at each visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Pelvic pain score (0 to 10), pain with intercourse and bowel movements, and missed working days | Every visit | Completed today | Worst pain 2 of 10; mild, occasional pain with intercourse; no missed work |
| Self-management | Bleeding pattern on continuous suppression | Every visit | Completed today | No periods |
| Medication safety | Combined pill: adherence, side effects, and reasons to stop estrogen (migraine with aura, high blood pressure, clot symptoms, smoking) | Every visit, with blood pressure | Completed today | Taken daily; blood pressure 112/70; no migraine with aura or clot symptoms |
| Medication safety | Naproxen: days used each month, and stomach or kidney symptoms | Every visit | Completed today | Two days this month |
| Medication safety | No opioid, benzodiazepine, or sleep-medicine accumulation; prescription monitoring program | At the start, then every visit while pain is active | Completed today | No opioid, benzodiazepine or sleep medicine |
| Imaging | Transvaginal ultrasound: endometrioma size and deep disease | At diagnosis; repeat at about four months on medical treatment, then yearly or if symptoms change | Completed today | Left endometrioma 3.1 by 2.6 cm, slightly smaller; no deep disease; next yearly |
| Examination | Pelvic examination | At diagnosis, and when pain persists or changes | Completed today | Pelvic floor relaxed; slight left tenderness |
| Referral | Surgical evaluation (laparoscopic excision) | If pain does not respond to medical treatment, the cyst grows, or imaging is atypical | Not indicated | Pain controlled and the cyst slightly smaller |
| Referral | Pelvic floor physical therapy | Weekly for six to eight weeks | Completed today | Six sessions; two more, then the home program |
| Self-management | Pregnancy intention and fertility plan | Every visit | Completed today | Wants to begin trying in about eight months; preconception visit planned; reproductive endocrinology after six months of trying |
| Survey | Depression measure (PHQ-9) | Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodically | Completed today | PHQ-9 4: remission |
| Survey | Anxiety measure (GAD-7) | At diagnosis and with each depression measure | Completed today | GAD-7 3 |
| Survey | Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan current |
| Self-management | Cognitive behavioral therapy engagement | Monthly in continuation | Completed today | Moving to monthly sessions |
| Self-management | Sleep without sedatives | Every visit | Completed today | Seven to eight hours without a sleep aid |

## Goal progress

- Worst pelvic pain 3 of 10 or less, and no missed working days for pain, by four months. Outcome by 2026-10-26: Worst pain 2 of 10; no missed working days for two months. **S**
- No opioid, benzodiazepine or sleep-medicine prescription, and naproxen on 10 days a month or fewer. Outcome by 2026-10-26: None prescribed; naproxen on two or three days a month; diphenhydramine stopped. **S**
- PHQ-9 score below 5 by four months. Outcome by 2026-10-26: PHQ-9 4. **S**
- A written plan for when and how to try for a pregnancy, made with her before the four-month visit. Outcome by 2026-10-26: Plan made: stop the pill when ready to try, after a preconception visit; reproductive endocrinology referral if not pregnant within six months. **S**

## Guideline basis

- Practice Bulletin No. 114: Management of Endometriosis (2010), American College of Obstetricians and Gynecologists (Obstetrics and Gynecology)
- ESHRE guideline: endometriosis (2022), European Society of Human Reproduction and Embryology (Human Reproduction Open)
- Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218 (2020), American College of Obstetricians and Gynecologists (Obstetrics and Gynecology)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- Anxiety Disorders in Adults: Screening (2023), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge

## Follow-up

- Two more physical therapy sessions. Behavioral health monthly. Preconception visit in about seven months; endometriosis review sooner if pain returns. **S**

